University of California San Francisco
Give to UCSF
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
Strengthening the link between Zika virus and microcephaly, scientists at UCSF have discovered that a protein the virus uses to infect skin cells and cause a rash is present also in stem cells of the developing human brain and retina.
Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer.
UCSF hosted a Zika symposium to bring together Bay Area experts and health officials to to help focus the research agenda as scientists around the world scrambling for information the virus.
Research by UCSF scientists has opened up a surprising new avenue for potential therapies to reduce the risk of type 2 diabetes and other metabolic disorders that are associated with chronic tissue inflammation in obesity.
Pregnant women can be protected from malaria, a major cause of prematurity, low birth weight and death in infants in Africa, with dihydroartemisinin-piperaquine (DP), an artemisinin combination therapy that is already widely used to treat malaria in adults, according to a study by researchers at UC San Francisco and in Uganda.
Leading microbiome researchers recently came to UCSF to share the newest insights about how improving our relationship with our bodies’ microbial ecosystems could be the next big breakthrough in treating metabolic disease.
Researchers at UCSF and Johns Hopkins may have found a new way to diagnose Lyme disease, based on a distinctive gene “signature” they discovered in white blood cells of patients infected with the tick-borne bacteria.
With a tiny sequencing machine that plugs into a laptop’s USB port, UCSF’s Charles Chiu aims to diagnose infectious diseases quickly – and even catch the next wave before it strikes.
UCSF scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.
The cells that create myelin, a fatty material that insulates nerve fibers in the brain’s white matter, migrate into the developing brain by climbing and swinging on blood vessels, according to new research led by UCSF scientists.
Three UCSF research fellows are exploring the role food insecurity plays in poor health related to infectious diseases, as part of the University of California Global Food Initiative.
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
The Malaria Elimination Group, an independent international advisory group on malaria elimination convened by the Global Health Group at the University of California, San Francisco (UCSF), gathered in the Ezulwini Valley for its tenth meeting to celebrate Swaziland’s achievements. The meeting was opened on November 16, 2015 by Swaziland’s Minister of Health, Honorable Sibongile Ndlela-Simelane.